These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 32081432)
21. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes. Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636 [TBL] [Abstract][Full Text] [Related]
22. Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. Jia D; Park JH; Jung KH; Levine H; Kaipparettu BA Cells; 2018 Mar; 7(3):. PubMed ID: 29534029 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas. Li Y; Li X; Kan Q; Zhang M; Li X; Xu R; Wang J; Yu D; Goscinski MA; Wen JG; Nesland JM; Suo Z Oncotarget; 2017 Jan; 8(1):1058-1073. PubMed ID: 27911865 [TBL] [Abstract][Full Text] [Related]
24. Mitochondrial and metabolic alterations in cancer cells. Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093 [TBL] [Abstract][Full Text] [Related]
25. β-alanine suppresses malignant breast epithelial cell aggressiveness through alterations in metabolism and cellular acidity in vitro. Vaughan RA; Gannon NP; Garcia-Smith R; Licon-Munoz Y; Barberena MA; Bisoffi M; Trujillo KA Mol Cancer; 2014 Jan; 13():14. PubMed ID: 24460609 [TBL] [Abstract][Full Text] [Related]
26. Chronic acidosis rewires cancer cell metabolism through PPARα signaling. Rolver MG; Holland LKK; Ponniah M; Prasad NS; Yao J; Schnipper J; Kramer S; Elingaard-Larsen L; Pedraz-Cuesta E; Liu B; Pardo LA; Maeda K; Sandelin A; Pedersen SF Int J Cancer; 2023 Apr; 152(8):1668-1684. PubMed ID: 36533672 [TBL] [Abstract][Full Text] [Related]
27. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Gatenby RA; Gawlinski ET Cancer Res; 2003 Jul; 63(14):3847-54. PubMed ID: 12873971 [TBL] [Abstract][Full Text] [Related]
28. Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review). Zuzčák M; Trnka J Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35730611 [TBL] [Abstract][Full Text] [Related]
30. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. Guido C; Whitaker-Menezes D; Capparelli C; Balliet R; Lin Z; Pestell RG; Howell A; Aquila S; Andò S; Martinez-Outschoorn U; Sotgia F; Lisanti MP Cell Cycle; 2012 Aug; 11(16):3019-35. PubMed ID: 22874531 [TBL] [Abstract][Full Text] [Related]
31. Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA. Hu D; Linders A; Yamak A; Correia C; Kijlstra JD; Garakani A; Xiao L; Milan DJ; van der Meer P; Serra M; Alves PM; Domian IJ Circ Res; 2018 Oct; 123(9):1066-1079. PubMed ID: 30355156 [TBL] [Abstract][Full Text] [Related]
32. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Lu J; Tan M; Cai Q Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809 [TBL] [Abstract][Full Text] [Related]
33. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma. Yang Y; Lane AN; Ricketts CJ; Sourbier C; Wei MH; Shuch B; Pike L; Wu M; Rouault TA; Boros LG; Fan TW; Linehan WM PLoS One; 2013; 8(8):e72179. PubMed ID: 23967283 [TBL] [Abstract][Full Text] [Related]
34. Drivers of the Warburg phenotype. Cairns RA Cancer J; 2015; 21(2):56-61. PubMed ID: 25815844 [TBL] [Abstract][Full Text] [Related]
35. Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer. Fidelito G; De Souza DP; Niranjan B; De Nardo W; Keerthikumar S; Brown K; Taylor RA; Watt MJ Mol Cancer Res; 2023 Apr; 21(4):359-373. PubMed ID: 36574015 [TBL] [Abstract][Full Text] [Related]
36. Molecular drivers of cellular metabolic reprogramming in melanoma. Abildgaard C; Guldberg P Trends Mol Med; 2015 Mar; 21(3):164-71. PubMed ID: 25618774 [TBL] [Abstract][Full Text] [Related]
37. Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells. Martinez-Outschoorn UE; Pestell RG; Howell A; Tykocinski ML; Nagajyothi F; Machado FS; Tanowitz HB; Sotgia F; Lisanti MP Cell Cycle; 2011 Dec; 10(24):4208-16. PubMed ID: 22033146 [TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in Cancer Metabolism: New Concepts in an Old Field. Gentric G; Mieulet V; Mechta-Grigoriou F Antioxid Redox Signal; 2017 Mar; 26(9):462-485. PubMed ID: 27228792 [TBL] [Abstract][Full Text] [Related]
39. PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer. Ji Q; Li H; Cai Z; Yuan X; Pu X; Huang Y; Fu S; Chu L; Jiang C; Xue J; Zhang X; Li R Int J Biol Sci; 2023; 19(6):1894-1909. PubMed ID: 37063425 [TBL] [Abstract][Full Text] [Related]
40. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression. Vaupel P; Schmidberger H; Mayer A Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]